What is PharmaScript?
PharmaScript Specialty Pharmacy focuses on delivering home infusion therapy, emphasizing medication needs through superior compounding accuracy and advanced technology. Established in 2016, the company partners with healthcare professionals and insurance providers to offer medications at reduced costs while improving patient health outcomes. PharmaScript serves patients requiring specialized pharmaceutical care, particularly in home settings, and provides compound medications nationwide, highlighting a strong commitment to patient well-being and accessibility.
How much funding has PharmaScript raised?
PharmaScript has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for PharmaScript?
With the recent strategic investment and substantial total funding, PharmaScript is poised for accelerated growth and expanded service offerings. This capital will likely fuel further technological advancements in compounding accuracy, enhance nationwide distribution capabilities, and strengthen collaborations with healthcare providers and insurers. The company's focus on patient-centric care and cost-effective solutions positions it for continued success in the competitive specialty pharmacy market, potentially leading to further market penetration and innovation in home infusion therapies.
See full PharmaScript company page
